Bavarian biotech worldwide Swiss Biotech Day 2025: Bavarian biotechnology with strong company presence With a well-attended BioM booth in the Global Village, high-quality contributions to the program and a strong corporate presence, Bavaria emphasised international innovation and collaboration at Swiss Biotech Day 2025. On 6 and 7 May 2025, BioM was once again represented at Swiss Biotech Day in Basel - one of the most important European meeting places for the biotech industry. With over 3,000 participants from 49 countries, 25 international delegations, more than 130 exhibitors and around 50 thematic pitches, roundtables and panels, the event once again proved its relevance as a central platform for networking, exchange and cooperation Bavarian biotechnology was very well represented by a BioM booth in the Global Village, which was frequented throughout both days of the event and thus demonstrated a clear interest in the Bavarian ecosystem. In addition to numerous discussions with international biotech, pharmaceutical and financial players from Switzerland and beyond, there was also broad interest in Bavarian start-ups, companies and location offers. One highlight was the Swiss-Bavarian Roundtable organised by BioM under the title ‘Bridging Ecosystems: Empowering Startups from Pre-Seed to Start-Up’. Designed as an ‘Innovation Journey’, the milestones in the life cycle of a biotech start-up were highlighted - each based on specific case studies. Read more © BioM LSX World Congress 2025: Successful first participation with a joint Bavarian booth For the first time, Bavaria presented itself with its own joint booth at the LSX World Congress 2025 in London - and very prominently: The Bavarian biotech cluster was at the centre of the exhibition area together with five Bavarian companies and with the support of Bayern International and the IGZ Würzburg. The aim was to showcase the innovative strength and competitiveness of the Bavarian life science ecosystem in the UK and in particular to investors. © BioM From 29 to 39 April 2025, the Bavarian life sciences scene presented itself at the LSX World Congress in London. The event brought together over 1,500 participants, including more than 500 investors and commercial leaders and over 250 speakers. 80% of the participants are either CxOs of up-and-coming life sciences companies, SVPs of the 30 largest pharmaceutical or T1 manufacturers or managing partners/partners of the most active investment firms in Europe/USA. The LSX World Congress thus offered an outstanding platform for targeted networking in the biotech, medtech and healthtech sectors. Read more Bavarian Biotech News, July 2025 www.bio-m.org 16